Your browser doesn't support javascript.
loading
Age-Dependent and Aß-Induced Dynamic Changes in the Subcellular Localization of HMGB1 in Neurons and Microglia in the Brains of an Animal Model of Alzheimer's Disease.
Seol, Song-I; Davaanyam, Dashdulam; Oh, Sang-A; Lee, Eun-Hwa; Han, Pyung-Lim; Kim, Seung-Woo; Lee, Ja-Kyeong.
Afiliação
  • Seol SI; Department of Anatomy, Inha University School of Medicine, Incheon 22212, Republic of Korea.
  • Davaanyam D; Department of Anatomy, Inha University School of Medicine, Incheon 22212, Republic of Korea.
  • Oh SA; Department of Anatomy, Inha University School of Medicine, Incheon 22212, Republic of Korea.
  • Lee EH; Department of Brain and Cognitive Sciences, Scranton College, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Han PL; Department of Brain and Cognitive Sciences, Scranton College, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Kim SW; Department of Chemistry and Nano Science, College of Natural Science, Ewha Womans University, Seoul 03760, Republic of Korea.
  • Lee JK; Department of Biomedical Sciences, Inha University School of Medicine, Inchon 22212, Republic of Korea.
Cells ; 13(2)2024 01 18.
Article em En | MEDLINE | ID: mdl-38247880
ABSTRACT
HMGB1 is a prototypical danger-associated molecular pattern (DAMP) molecule that co-localizes with amyloid beta (Aß) in the brains of patients with Alzheimer's disease. HMGB1 levels are significantly higher in the cerebrospinal fluid of patients. However, the cellular and subcellular distribution of HMGB1 in relation to the pathology of Alzheimer's disease has not yet been studied in detail. Here, we investigated whether HMGB1 protein levels in brain tissue homogenates (frontal cortex and striatum) and sera from Tg-APP/PS1 mice, along with its cellular and subcellular localization in those regions, differed. Total HMGB1 levels were increased in the frontal cortices of aged wildtype (7.5 M) mice compared to young (3.5 M) mice, whereas total HMGB1 levels in the frontal cortices of Tg-APP/PS1 mice (7.5 M) were significantly lower than those in age-matched wildtype mice. In contrast, total serum HMGB1 levels were enhanced in aged wildtype (7.5 M) mice and Tg-APP/PS1 mice (7.5 M). Further analysis indicated that nuclear HMGB1 levels in the frontal cortices of Tg-APP/PS1 mice were significantly reduced compared to those in age-matched wildtype controls, and cytosolic HMGB1 levels were also significantly decreased. Triple-fluorescence immunohistochemical analysis indicated that HMGB1 appeared as a ring shape in the cytoplasm of most neurons and microglia in the frontal cortices of 9.5 M Tg-APP/PS1 mice, indicating that nuclear HMGB1 is reduced by aging and in Tg-APP/PS1 mice. Consistent with these observations, Aß treatment of both primary cortical neuron and primary microglial cultures increased HMGB1 secretion in the media, in an Aß-dose-dependent manner. Our results indicate that nuclear HMGB1 might be translocated from the nucleus to the cytoplasm in both neurons and microglia in the brains of Tg-APP/PS1 mice, and that it may subsequently be secreted extracellularly.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Proteína HMGB1 / Doença de Alzheimer Limite: Aged / Animals / Humans Idioma: En Revista: Cells Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Peptídeos beta-Amiloides / Proteína HMGB1 / Doença de Alzheimer Limite: Aged / Animals / Humans Idioma: En Revista: Cells Ano de publicação: 2024 Tipo de documento: Article